As of 2024-12-12, the Intrinsic Value of Kala Pharmaceuticals Inc (KALA) is
-45.77 USD. This KALA valuation is based on the model Peter Lynch Fair Value.
With the current market price of 6.21 USD, the upside of Kala Pharmaceuticals Inc is
-836.99%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
-45.77 USD
Intrinsic Value
KALA Intrinsic Value - Valuation Summary
|
Range |
Selected |
Upside |
| a |
| Fair Value |
-45.77 - -45.77 |
-45.77 |
-836.99% |
| P/E |
(126.68) - (207.23) |
(162.01) |
-2708.9% |
| DDM - Stable |
(110.44) - (653.46) |
(381.95) |
-6250.5% |
| DDM - Multi |
(107.92) - (498.39) |
(177.62) |
-2960.2% |
KALA Intrinsic Value - Key Valuation Metrics
| Market Cap (mil) |
28.63 |
| Beta |
0.50 |
| Outstanding shares (mil) |
4.61 |
| Enterprise Value (mil) |
14.57 |
| Market risk premium |
4.60% |
| Cost of Equity |
7.53% |
| Cost of Debt |
5.00% |
| WACC |
5.52% |